Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Income from Non-Controlling Interests (2016)

Kiora Pharmaceuticals' Income from Non-Controlling Interests history spans 2 years, with the latest figure at -$1.51 for Q4 2016.

  • For Q4 2016, Income from Non-Controlling Interests rose 100.0% year-over-year to -$1.51; the TTM value through Dec 2016 reached -$1.51, up 100.0%, while the annual FY2017 figure was -$0.93, 38.41% up from the prior year.
  • Income from Non-Controlling Interests reached -$1.51 in Q4 2016 per KPRX's latest filing, up from -$32967.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$1.51 in Q4 2016 to a low of -$32967.0 in Q4 2015.